Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 3
Submit an article Journal homepage
18
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Use of Iodine 131I-Tositumomab Radioimmunotherapy in a Patient with Waldenstrom's Macroglobulinemia

Donald E Tsai Bone Marrow and Stem Cell Transplant Program, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, 19104, USACorrespondence[email protected]
,
Ivan Maillard Division of Nuclear Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, 19104, USA
,
Lisa H Downs Department of Radiation Oncology, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, 19104, USA
,
Abass Alavi Bone Marrow and Stem Cell Transplant Program, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, 19104, USA
,
Sunita D Nasta Division of Nuclear Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, 19104, USA
,
Eli Glatstein Department of Radiation Oncology, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, 19104, USA
&
Stephen J Schuster Bone Marrow and Stem Cell Transplant Program, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, 19104, USA
 show all
Pages 591-595 | Received 16 Jun 2003, Published online: 03 Aug 2009

References

  • Kyle, R.A. and Garton, J.P. (1987) "The spectrum of IgM monoclonal gammopathy in 430 cases", Mayo Clinic Proceedings, 62, 719–731.
  • Zelenetz, A.D. (1999) "Radioimmunotherapy for lymphoma", Current Opinion in Oncology, 11, 375–380.
  • Goldenberg, D.M. (2001) "The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy", Critical Review in Oncology/ Hematology, 39, 195–201.
  • Vose, J.M., Wahl, R.L., Saleh, M.N., Rohatiner, A.Z., Knox, Si., Radford, J.A., et al. (2000) "Multicenter Phase II Study of Iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphoma", Journal of Clinical Oncology, 18, 1316— 1323.
  • Kaminski, M.S., Estes, J., Zasadny, KR., Francis, JR., Ross, C.W., Regan, D., et al. (2000) "Radioimmunotherapy with iodine 1311 tositumomab for relapsed or refractory B-cell non-Hodgkin's lymphoma: updated results and long-term follow-up of the University of Michigan experience", Blood, 96, 1259–1266.
  • Kaminski, M.S., Zelenetz, A.D., Press, O.W., Saleh, M.N., Leonard, J., Fehrenbacher, L., et al. (2001) "Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphoma", Journal of Clinical Oncology, 19, 3918–3928.
  • Goldenberg, D.M., Horowitz, JA., Sharkey, R.M., Hall, T.C., Murthy, S., Goldenberg, H., et al. (1991) "Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody", Journal of Clinical Oncology, 9, 548— 564.
  • Zhang, M., Zhang, Z., Garmestani, K., Schultz, J., Axworthy, D.B., Goldman, C.K., et al. (2003) "Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts", Proceedings of the National Academy of Sciences USA, 100, 1891–1895.
  • Witzig, T.E., White, CA., Wiseman, G., Gordon, L.I., Emmanoui-lides, C., Raubitshek, A., et al. (1999) "Phase I/II trial of IDEC-Y2B8 Radioimmunotherapy for treatment of relapsed or refractory CD20 + B-cell non-Hodgkin's lymphoma", Journal of Clinical Oncology, 17, 3793 — 3803.
  • DeNardo, G.L., DeNardo, Si., Goldstein, DS., Kroger, L.A., Lamborn, KR., Levy, N.B., et al. (1998) "Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for frac-tionated radioimmunotherapy of non-Hodgkin's lymphoma", Journal of Clinical Oncology, 16, 3246— 3256.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.